Heidi Hunter is President of Cardinal Health Specialty Solutions, a specialty healthcare business that helps healthcare providers and pharmaceutical companies optimize business success and drive improved patient care. Heidi is an accomplished global healthcare leader with deep experience in innovation, development and commercialization of specialty pharmaceuticals. She began her career in sales and marketing at Ciba-Geigy in Switzerland, then moved to Novo Nordisk in Denmark and later Wyeth (today part of Pfizer) in the US where she led their oncology business. She served as Senior Vice President and General Manager at Boehringer Ingelheim where she built and led their global biosimilars business. She also held senior leadership roles in marketing and commercialization for biologics and oncology at Centocor, a J&J company. Most recently, she was Senior Vice President of the Global Immunology business unit at UCB in Brussels. Heidi holds an MBA from The University of Chicago.
For truly personalized cell and gene therapies to become standard of care, we must continue to leverage and successfully implement advances in science, technology, automation and digitization to scale the process and shorten the time it takes to get lifesaving medicines to patients in need.